Clinical Trial Update: Safety and Feasibility Evaluation of the APS APP [Phase 2, Phase 3]

View source ↗

Summary

Safety and feasibility evaluation of the APS APP in Phase 2/Phase 3 for Type 1 Diabetes Mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• APS APP

Snippet

Sponsor: Sansum Diabetes Research Institute | Conditions: Type 1 Diabetes Mellitus | Phase 2, Phase 3 | Status: COMPLETED